Molecular Imaging & Therapy

Breast Cancer Imaging Trials

• (163-22) SSTR targeted imaging for patients with breast cancer.
• (182-20) Estrogen receptor-targeted imaging compared to standard-of-care Imaging in patients with breast cancer (Open to patients with newly diagnosed and suspected recurrence of estrogen receptor-positive breast cancer)
• (163-22) SSTR targeted imaging for patients with breast cancer. (pending NCT #)
• (206-21) Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients
• (207-21) A Phase I/IIa Study of the SV-BR-1-GM Regimen in Metastatic or Locally Recurrent Breast Cancer Patients in Combination with Retifanlimab and Epacadostat

Myeloma Imaging Trial 

• (177-20) CD38-targeted ImmunoPET of Myeloma (Open to patients with multiple myeloma that is either newly diagnosed or with planned change in therapy)

Prostate Cancer Therapy Trials

• (114-20) Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone (ARROW)
• (222-21) PSMA-targeted therapy for patients with prostate cancer (SPLASH).
• (232-21) PSMA-targeted therapy for patients with prostate cancer (ECLIPSE).

Neuroendocrine Targeted Therapy Trial

• (173-22) SSTR targeted therapy for patients with neuroendocrine tumors)

Certain clinical trials may not be listed on ClinicalTrials.gov. To learn more about these or other clinical trials, please call 949-764-4577